After several years of declining revenues, top generic drug maker Teva Pharmaceuticals will turn to high-priced biotech medications in an effort to jumpstart growth, The Wall Street Journal reports.
Pharmacy
A federal judge has ruled that AbbVie must turn over documents in a lawsuit that accuses the drugmaker of using "unclean hands" to create a thicket of patents to protect its best-selling drug Humira from competition, according to STAT.
Ahead of the 2020 presidential race, New Jersey Democrat Sen. Cory Booker is working to shed his reputation of being a friend of the pharmaceutical industry, STAT reports.
Johnson & Johnson will shell out $3.4 billion in cash to buy robotic surgery company Auris Health, CNBC reports.
CVS Health has unveiled three redesigned health-focused concept stores in the Houston market, according to CNBC.
Advertisement
The U.S. Securities and Exchange Commission told Johnson & Johnson it can choose not to hold a shareholder vote on a proposal that would send all shareholder disputes to private arbitration hearings rather than federal court, according to The Wall…
As part of a restructuring effort, Seres Therapeutics, a Cambridge, Mass.-based drugmaker developing biological treatments, will cut 30 percent of its workforce and make changes to its executive team.
The FDA accused 17 nutritional supplement companies of illegally marketing more than 58 products with claims that they can prevent, treat or cure serious diseases.
Seth Hartman, PharmD, serves as director of pharmacy informatics at University of Chicago Medicine, an 811-bed academic medical center.
Following its peers, Pfizer and Merck, Sanofi has appointed its first chief digital officer, according to Endpoints News.